source
- Neurosterix nabs $105M, recruits Karuna veterans for schizophrenia pushAddex Therapeutics spinout Neurosterix will use the series B funds to advance an oral drug targeting M4, a muscarinic receptor also targeted by BMS’ Cobenfy, which introduced a new mechanism for tr…BioSpace · 1h ago↗ source
- Bristol Myers research chief to depart in ‘evolution’ of company’s structureRobert Plenge is leaving as part of a shift that will see the company merge together its R&D department in a bid to speed development and capitalize on new technologies.BioPharma Dive · 1h ago↗ source
- STAT+: Scientists debut map of basal ganglia, a key brain region involved in an array of diseasesA massive scientific collaboration has produced the most detailed map yet of the basal ganglia, a key brain region involved in an array of psychiatric and neurologic disorders.